반응형
Global Data Intelligence Center
구분 보고서 (영문) 업로드 날짜
제약/바이오/
임상시험
Merck Bets Big on PRA023 and Inflammatory Bowel Diseases With $10.8B Prometheus Acquisition Offer 04-28-2023
NICE Recommends First Treatment for Incurable Cervical Cancer in 14 Years
04-27-2023
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Colombia
04-27-2023
AZ to Terminate Once-Daily Cotadutide Program to Focus on Weekly GLP-1RA Co-Agonist
04-25-2023
As Cytokinetics’s ALS Drug Fails Phase III Trial, Attention Turns to Cardiomyopathy Candidate
04-24-2023
FDA Has Pushed Back on Approving Mirikizumab Due to Manufacturing Issues
04-20-2023
OncoSec’s Tavo Reaches Tipping Point with Latest Phase IIb Results
04-20-2023
Moderna Announces Development of New Treatments for Lyme Disease
04-20-2023
Bristol Myers Squibb’s Blockbuster Sotyktu Scores European Nod for Plaque Psoriasis 04-20-2023


질환별
Melanoma: Cell & Gene Therapies 15-Market Assessment and Forecast
04-28-2023
Body Dysmorphic Disorder: Competitive Landscape
04-27-2023
Allergic Conjunctivitis: Competitive Landscape
04-21-2023
Idiopathic Pulmonary Fibrosis: Competitive Landscape
04-20-2023
컨퍼런스/
심포지엄/

학회 등
AAN 2023: Importance of Education for Levodopa Infusions in Parkinson’s
04-26-2023
AAN 2023: AbbVie Highlights Qulipta’s Edge over Oral Migraine Prophylaxis
04-26-2023
AAN 2023: Amneal’s IPX203 Shows Promise for Parkinson’s Disease Patients
04-26-2023
Highlights from AACR 2023: KRAS Inhibitor Pipeline Candidates Gain Momentum
04-26-2023
AACR 2023: TRAVERSE - First-in-Human Trial of Allogeneic Anti-CD70 CAR-T Candidate Shows Promise for Advanced Renal Cell Carcinoma
04-24-2023
ECCMID 2023: Highlights on findings for viral, bacterial, and fungal infections in 2022
04-21-2023
ECCMID 2023: Updating the Global Bacterial Priority Pathogens List
04-21-2023

 

반응형
반응형
Global Data Intelligence Center
구분 보고서 (영문) 업로드
날짜
제약/바이오/
임상시험
Contract Manufacturing: Opportunities and Threats – March 2023 04-19-2023
Contract Service Agreements – March 2023 04-19-2023
Arrowhead Pharmaceuticals to Target Unmet Needs in Rare Lipid Disorders 04-19-2023
March Quarterly Contract Manufacturing Mergers, Acquisitions, and Financing – Q1 2023 04-19-2023
Bayer Plans to Scale Back Women’s Health R&D 04-19-2023
Over 2,000 Drugs in Japan Undergo an Average Reduction of 9.0% in April, Including NHI-Related Price Adjustments 04-18-2023
Multiple Sclerosis Market to Generate Sales of $29.8 Billion by 2030 04-18-2023
Combination of Merck’s Keytruda with Eisai’s Lenvima Fail Phase III Trial in Front-line Melanoma 04-17-2023
Global Risk Report (Quarterly Update) Q4 2022 04-06-2023
Maven Clinic, a Telehealth Platform, Is the First Women's and Family Health Company in the US to Reach Unicorn Status 04-03-2023
New Drug Approvals and Their Contract Manufacture: 2023 Edition 04-03-2023
FDA $7.2 Billion Plans for 2024: Disclose Contract Manufacturers, Stricter on Shortages and Recalls 03-31-2023
 
질환별
Unmet Needs in the Obesity Market 04-13-2023
Respiratory Syncytial Virus (RSV): Competitive Landscape 04-10-2023
Multiple Sclerosis: Seven-Market Drug Forecast and Market Analysis to 2030 – Update 04-07-2023
Ulcerative Colitis: Eight-Market Drug Forecast and Market Analysis 04-04-2023
Mucopolysaccharidosis II (MPS II): Competitive Landscape 03-31-2023
Systemic Lupus Erythematosus and Lupus Nephritis: Seven-Market Drug Forecast and Market Analysis to 2031 03-31-2023
컨퍼런스/
심포지엄/

학회 등
AACR 2023: Moderna’s mRNA-4157 Paves the Way for Personalized Cancer Vaccines in High-Risk Melanoma 04-18-2023
AD/PD 2023: What Role Could Blood-Based Biomarkers Play in the Future Diagnosis of AD? 04-03-2023
AD/PD 2023: Challenges in Clinical Trial Design for DMTs in PD 04-03-2023

 

 

반응형
반응형

국내에서 임상시험을 계획 중인 제약·바이오기업, CRO 대상으로 「임상시험 타당성 조사(Feasibility) 지원사업」을 수행

 

 

[KoNECT] Feasibility 서비스 홍보자료_최종.pdf
14.24MB

반응형
반응형

 

Global Data Intelligence Center
구분 보고서 (영문) 업로드 날짜
제약/바이오/임상시험 Q1 Claimed the Highest Number of Trial Starts in 2022 03-31-2023
Emerging Market Outsourcing Report – Q1 2023 03-31-2023
Reinforcement for AbbVie’s Skyrizi and Promise for Takeda’s TAK-279 in Plaque Psoriasis at AAD 2023 03-31-2023
Bio/Pharmaceutical Outsourcing Report, March 2023 03-31-2023
Latest WHO COVID-19 Vaccine Guidance May Decrease Future Demand 03-31-2023
AD/PD 2023: Lecanemab Quality of Life Data Highlights Value for Patients and Caregivers 03-31-2023
AD/PD 2023: Lilly Highlights Potential Durability of Treatment with Donanemab 03-31-2023
 
질환별
Obsessive-Compulsive Disorder (OCD): Competitive Landscape 03-31-2023
Myelofibrosis: Eight-Market Drug Forecast and Market Analysis 03-31-2023
Obesity: 68-Market Analysis and Sales Forecast 03-31-2023
Unmet Needs in the Lupus Market 03-31-2023
Mucopolysaccharidosis II (MPS II): Competitive Landscape 03-31-2023

 

 

반응형

+ Recent posts